PS 15. Testosterone therapy in hypogonadal men with sickle cell disease
Plenary Session

PS 15. Testosterone therapy in hypogonadal men with sickle cell disease

Arthur Burnett

Professor of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-2101, USA

This presentation serves to describe the observation of testosterone deficiency in patients with sickle cell disease and the potential role of testosterone replacement therapy to manage hypogonadism and sexual dysfunction in this patient population.

DOI: 10.3978/j.issn.2223-4683.2012.s253

Article Options

Download Citation

Share